APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Growth and Trends Forecast to 2032

22 December 202592 pages

Choose your research edition.

Industry ResearchRecombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine include Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline Plc, Serum Institute of India, Sanofi Pasteur, Emergent Biosolutions and CSL Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market size, estimates, and forecasts are presented in terms of sales volume (doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Company

Johnson & Johnson

Merck & Co., Inc.

Pfizer Inc.

GlaxoSmithKline Plc

Serum Institute of India

Sanofi Pasteur

Emergent Biosolutions

CSL Limited

Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Type

Pediatric Hepatitis B (CHO) Vaccine

Adult Hepatitis B (CHO) Vaccine

Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Application

Hospitals

Clinics

Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pediatric Hepatitis B (CHO) Vaccine Table 2. Major Company of Adult Hepatitis B (CHO) Vaccine Table 3. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (doses) Table 5. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2021-2026) & (US$/dose) Table 9. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2027-2032) & (doses) Table 10. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2027-2032) & (US$/dose) Table 14. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (doses) Table 15. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (doses) Table 17. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (doses) Table 19. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (doses) Table 21. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (doses) Table 23. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Trends Table 25. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Drivers Table 26. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Opportunities and Challenges Table 27. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Restraints Table 28. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Company (2021-2026) & (doses) Table 31. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Company (2021-2026) Table 32. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Price by Company (2021-2026) & (US$/dose) Table 33. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Major Company Production Sites and Headquarters Table 35. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Company, Product Type & Application Table 36. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2021-2026) & (doses) Table 41. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 45. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2027-2032) & (doses) Table 46. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2027-2032) Table 50. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (doses) Table 52. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application (2021-2026) & (US$/dose) Table 56. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2027-2032) & (doses) Table 57. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application (2027-2032) & (US$/dose) Table 61. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (doses) Table 62. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (doses) Table 64. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (doses) Table 66. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (doses) Table 68. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (doses) Table 70. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Johnson & Johnson Company Information Table 72. Johnson & Johnson Business Overview Table 73. Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 74. Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio Table 75. Johnson & Johnson Recent Development Table 76. Merck & Co., Inc. Company Information Table 77. Merck & Co., Inc. Business Overview Table 78. Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 79. Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio Table 80. Merck & Co., Inc. Recent Development Table 81. Pfizer Inc. Company Information Table 82. Pfizer Inc. Business Overview Table 83. Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 84. Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio Table 85. Pfizer Inc. Recent Development Table 86. GlaxoSmithKline Plc Company Information Table 87. GlaxoSmithKline Plc Business Overview Table 88. GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 89. GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio Table 90. GlaxoSmithKline Plc Recent Development Table 91. Serum Institute of India Company Information Table 92. Serum Institute of India Business Overview Table 93. Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 94. Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio Table 95. Serum Institute of India Recent Development Table 96. Sanofi Pasteur Company Information Table 97. Sanofi Pasteur Business Overview Table 98. Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 99. Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio Table 100. Sanofi Pasteur Recent Development Table 101. Emergent Biosolutions Company Information Table 102. Emergent Biosolutions Business Overview Table 103. Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 104. Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio Table 105. Emergent Biosolutions Recent Development Table 106. CSL Limited Company Information Table 107. CSL Limited Business Overview Table 108. CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 109. CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio Table 110. CSL Limited Recent Development Table 111. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 112. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2026) & (doses) Table 113. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2021-2026) Table 114. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Country (2027-2032) & (doses) Table 115. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share Forecast by Country (2027-2032) Table 116. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Country (2021-2026) Table 119. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share Forecast by Country (2027-2032) Table 121. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 122. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2026) & (doses) Table 123. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2021-2026) Table 124. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Country (2027-2032) & (doses) Table 125. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Country (2021-2026) Table 129. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2026) & (doses) Table 133. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Country (2027-2032) & (doses) Table 135. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Country (2021-2026) Table 139. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share Forecast by Country (2027-2032) Table 141. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 142. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2026) & (doses) Table 143. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2021-2026) Table 144. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Country (2027-2032) & (doses) Table 145. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Country (2021-2026) Table 149. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2026) & (doses) Table 153. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Country (2027-2032) & (doses) Table 155. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Country (2021-2026) Table 159. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors List Table 164. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Image Figure 2. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (2021-2032) & (doses) Figure 5. Pediatric Hepatitis B (CHO) Vaccine Image Figure 6. Global Pediatric Hepatitis B (CHO) Vaccine Sales YoY Growth (2021-2032) & (doses) Figure 7. Adult Hepatitis B (CHO) Vaccine Image Figure 8. Global Adult Hepatitis B (CHO) Vaccine Sales YoY Growth (2021-2032) & (doses) Figure 9. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospitals Image Figure 24. Global Hospitals Sales YoY Growth (2021-2032) & (doses) Figure 25. Clinics Image Figure 26. Global Clinics Sales YoY Growth (2021-2032) & (doses) Figure 27. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 40. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 44. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 48. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 52. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 56. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Pediatric Hepatitis B (CHO) Vaccine
  • Adult Hepatitis B (CHO) Vaccine
Applications
  • Hospitals
  • Clinics
Companies covered
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
  • GlaxoSmithKline Plc
  • Serum Institute of India
  • Sanofi Pasteur
  • Emergent Biosolutions
  • CSL Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
  6. 1.3.1 Pediatric Hepatitis B (CHO) Vaccine
  7. 1.3.2 Adult Hepatitis B (CHO) Vaccine
  8. 1.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Type
  9. 1.4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Trends
  2. 2.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Drivers
  3. 2.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Opportunities and Challenges
  4. 2.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (2021-2026)
  4. 3.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Company, Product Type & Application
  7. 3.7 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Tier 1, Tier 2, and Tier 3
4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Regional Status and Outlook
  1. 4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Historic Market Size by Region
  3. 4.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Application
  1. 5.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Application
  5. 5.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Merck & Co., Inc.
  8. 6.2.1 Merck & Co., Inc. Company Information
  9. 6.2.2 Merck & Co., Inc. Business Overview
  10. 6.2.3 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
  12. 6.2.5 Merck & Co., Inc. Recent Developments
  13. 6.3 Pfizer Inc.
  14. 6.3.1 Pfizer Inc. Company Information
  15. 6.3.2 Pfizer Inc. Business Overview
  16. 6.3.3 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
  18. 6.3.5 Pfizer Inc. Recent Developments
  19. 6.4 GlaxoSmithKline Plc
  20. 6.4.1 GlaxoSmithKline Plc Company Information
  21. 6.4.2 GlaxoSmithKline Plc Business Overview
  22. 6.4.3 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
  24. 6.4.5 GlaxoSmithKline Plc Recent Developments
  25. 6.5 Serum Institute of India
  26. 6.5.1 Serum Institute of India Company Information
  27. 6.5.2 Serum Institute of India Business Overview
  28. 6.5.3 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
  30. 6.5.5 Serum Institute of India Recent Developments
  31. 6.6 Sanofi Pasteur
  32. 6.6.1 Sanofi Pasteur Company Information
  33. 6.6.2 Sanofi Pasteur Business Overview
  34. 6.6.3 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
  36. 6.6.5 Sanofi Pasteur Recent Developments
  37. 6.7 Emergent Biosolutions
  38. 6.7.1 Emergent Biosolutions Company Information
  39. 6.7.2 Emergent Biosolutions Business Overview
  40. 6.7.3 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
  42. 6.7.5 Emergent Biosolutions Recent Developments
  43. 6.8 CSL Limited
  44. 6.8.1 CSL Limited Company Information
  45. 6.8.2 CSL Limited Business Overview
  46. 6.8.3 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
  48. 6.8.5 CSL Limited Recent Developments
7 North America by Country
  1. 7.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country
  2. 7.1.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country
  6. 7.2.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country
  2. 8.1.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country
  6. 8.2.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country
  2. 10.1.1 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country
  6. 10.2.1 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Value Chain Analysis
  2. 12.1.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Mode & Process
  7. 12.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors
  10. 12.2.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst